KURN — Kuros Biosciences AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Annual balance sheet for Kuros Biosciences AG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	C2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	fx Final	fx Final	fx Final
Cash
Cash and Short Term Investments	32.1	31.4	26	16.9	19.9
Net Total Accounts Receivable
Net Total Receivables	1.58	2.24	3.91	9.05	17.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	38.4	36.1	34	32.3	49.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.92	2.68	2.51	3.14	3.33
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	107	100	89.7	84.9	93.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.38	12.4	13.6	11.7	23
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	11	15.7	15.2	17.5	28.4
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	95.6	84.4	74.5	67.4	64.8
Total Liabilities & Shareholders' Equity	107	100	89.7	84.9	93.2
Total Common Shares Outstanding